19540952

Source:http://linkedlifedata.com/resource/pubmed/id/19540952

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0016627, umls-concept:C0021403, umls-concept:C0220825, umls-concept:C0332161, umls-concept:C1548795
pubmed:issue	36
pubmed:dateCreated	2009-7-22
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00347672, http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00488046
pubmed:abstractText	Development of live attenuated influenza vaccines (LAIV) against avian viruses with pandemic potential is an important public health strategy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/N01-AI-15444
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8406899
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Influenza Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Attenuated
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1873-2518
pubmed:author	pubmed-author:CallahanKarenK, pubmed-author:ChenGraceG, pubmed-author:CoelinghKathleenK, pubmed-author:DilorenzoSusanS, pubmed-author:JinHongH, pubmed-author:KarronRuth ARA, pubmed-author:KembleGeorgeG, pubmed-author:LamirandeElaineE, pubmed-author:LukeCatherineC, pubmed-author:McAuliffeJosephineJ, pubmed-author:MillsKimberlyK, pubmed-author:MurphyBrian RBR, pubmed-author:SchappellElizabethE, pubmed-author:SubbaraoKantaK, pubmed-author:SuguitanAmorsoloA, pubmed-author:TalaatKawsarK, pubmed-author:ThumarBhagvanjiB
pubmed:issnType	Electronic
pubmed:day	6
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4953-60
pubmed:meshHeading	pubmed-meshheading:19540952-Adolescent, pubmed-meshheading:19540952-Adult, pubmed-meshheading:19540952-Antibodies, Viral, pubmed-meshheading:19540952-Female, pubmed-meshheading:19540952-Hemagglutination Inhibition Tests, pubmed-meshheading:19540952-Humans, pubmed-meshheading:19540952-Immunization, Secondary, pubmed-meshheading:19540952-Immunoglobulin A, pubmed-meshheading:19540952-Immunoglobulin G, pubmed-meshheading:19540952-Influenza, Human, pubmed-meshheading:19540952-Influenza A Virus, H5N1 Subtype, pubmed-meshheading:19540952-Influenza Vaccines, pubmed-meshheading:19540952-Male, pubmed-meshheading:19540952-Middle Aged, pubmed-meshheading:19540952-Nasal Mucosa, pubmed-meshheading:19540952-Neutralization Tests, pubmed-meshheading:19540952-Vaccines, Attenuated, pubmed-meshheading:19540952-Young Adult
pubmed:year	2009
pubmed:articleTitle	Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
pubmed:affiliation	Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States. rkarron@jhsph.edu
pubmed:publicationType	Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I, Research Support, N.I.H., Extramural